CN110197701A - 一种新型多发性骨髓瘤诺模图构建方法 - Google Patents
一种新型多发性骨髓瘤诺模图构建方法 Download PDFInfo
- Publication number
- CN110197701A CN110197701A CN201910325039.3A CN201910325039A CN110197701A CN 110197701 A CN110197701 A CN 110197701A CN 201910325039 A CN201910325039 A CN 201910325039A CN 110197701 A CN110197701 A CN 110197701A
- Authority
- CN
- China
- Prior art keywords
- gene
- expression
- module
- genes
- construction method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000010099 disease Diseases 0.000 title claims abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 14
- 238000010276 construction Methods 0.000 title claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 60
- 230000014509 gene expression Effects 0.000 claims abstract description 51
- 230000004083 survival effect Effects 0.000 claims abstract description 13
- 102000015736 beta 2-Microglobulin Human genes 0.000 claims abstract description 8
- 108010081355 beta 2-Microglobulin Proteins 0.000 claims abstract description 8
- 238000003012 network analysis Methods 0.000 claims abstract description 7
- 210000002966 serum Anatomy 0.000 claims abstract description 7
- 238000004458 analytical method Methods 0.000 claims abstract description 5
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 14
- 102000001554 Hemoglobins Human genes 0.000 claims description 8
- 108010054147 Hemoglobins Proteins 0.000 claims description 8
- 229940109239 creatinine Drugs 0.000 claims description 7
- 108010074051 C-Reactive Protein Proteins 0.000 claims description 6
- 102100032752 C-reactive protein Human genes 0.000 claims description 6
- 101001027634 Homo sapiens Kinesin-like protein KIF21B Proteins 0.000 claims description 5
- 101001002191 Homo sapiens Postmeiotic segregation increased 2-like protein 5 Proteins 0.000 claims description 5
- 102100020952 Postmeiotic segregation increased 2-like protein 5 Human genes 0.000 claims description 5
- 210000001185 bone marrow Anatomy 0.000 claims description 5
- 210000004180 plasmocyte Anatomy 0.000 claims description 5
- 101710088194 Dehydrogenase Proteins 0.000 claims description 4
- 102100024175 Centriole, cilia and spindle-associated protein Human genes 0.000 claims description 3
- 102100025832 Centromere-associated protein E Human genes 0.000 claims description 3
- 108010009392 Cyclin-Dependent Kinase Inhibitor p16 Proteins 0.000 claims description 3
- 102100030421 Fatty acid-binding protein 5 Human genes 0.000 claims description 3
- 101000980796 Homo sapiens Centriole, cilia and spindle-associated protein Proteins 0.000 claims description 3
- 101000914247 Homo sapiens Centromere-associated protein E Proteins 0.000 claims description 3
- 101000802406 Homo sapiens E3 ubiquitin-protein ligase ZNRF3 Proteins 0.000 claims description 3
- 101001062855 Homo sapiens Fatty acid-binding protein 5 Proteins 0.000 claims description 3
- 101000837008 Homo sapiens Sigma intracellular receptor 2 Proteins 0.000 claims description 3
- 101000837581 Homo sapiens Ubiquitin-conjugating enzyme E2 T Proteins 0.000 claims description 3
- 102100037690 Kinesin-like protein KIF21B Human genes 0.000 claims description 3
- 108091006941 SLC39A10 Proteins 0.000 claims description 3
- 102100028662 Sigma intracellular receptor 2 Human genes 0.000 claims description 3
- 102100028705 Ubiquitin-conjugating enzyme E2 T Human genes 0.000 claims description 3
- 102000006083 ZNRF3 Human genes 0.000 claims description 3
- 102100035243 Zinc transporter ZIP10 Human genes 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 235000012571 Ficus glomerata Nutrition 0.000 claims description 2
- 244000153665 Ficus glomerata Species 0.000 claims description 2
- 102100034613 Annexin A2 Human genes 0.000 claims 1
- 108090000668 Annexin A2 Proteins 0.000 claims 1
- 102100024458 Cyclin-dependent kinase inhibitor 2A Human genes 0.000 claims 1
- 230000004077 genetic alteration Effects 0.000 claims 1
- 231100000118 genetic alteration Toxicity 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000000523 sample Substances 0.000 description 25
- 208000034578 Multiple myelomas Diseases 0.000 description 19
- 206010035226 Plasma cell myeloma Diseases 0.000 description 19
- 238000012360 testing method Methods 0.000 description 19
- 238000012549 training Methods 0.000 description 12
- 238000004393 prognosis Methods 0.000 description 7
- 238000001228 spectrum Methods 0.000 description 7
- 238000011088 calibration curve Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000000611 regression analysis Methods 0.000 description 4
- 101150041972 CDKN2A gene Proteins 0.000 description 2
- 101150012801 Ccsap gene Proteins 0.000 description 2
- 101150050296 Cenpe gene Proteins 0.000 description 2
- 102000009508 Cyclin-Dependent Kinase Inhibitor p16 Human genes 0.000 description 2
- 101100202313 Danio rerio slc39a10 gene Proteins 0.000 description 2
- 101150077503 Fabp5 gene Proteins 0.000 description 2
- 101100202314 Homo sapiens SLC39A10 gene Proteins 0.000 description 2
- 101100202315 Mus musculus Slc39a10 gene Proteins 0.000 description 2
- 101150020537 Tmem97 gene Proteins 0.000 description 2
- 101150041027 ZNRF3 gene Proteins 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 108700042657 p16 Genes Proteins 0.000 description 2
- 101150117250 slc39a10 gene Proteins 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 101150071951 ube2t gene Proteins 0.000 description 2
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 238000010824 Kaplan-Meier survival analysis Methods 0.000 description 1
- 208000002774 Paraproteinemias Diseases 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 238000003705 background correction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 208000010626 plasma cell neoplasm Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Data Mining & Analysis (AREA)
- Public Health (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Artificial Intelligence (AREA)
- Primary Health Care (AREA)
- Evolutionary Computation (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Biomedical Technology (AREA)
- Bioethics (AREA)
- Pathology (AREA)
- Software Systems (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910325039.3A CN110197701B (zh) | 2019-04-22 | 2019-04-22 | 一种新型多发性骨髓瘤诺模图构建方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910325039.3A CN110197701B (zh) | 2019-04-22 | 2019-04-22 | 一种新型多发性骨髓瘤诺模图构建方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110197701A true CN110197701A (zh) | 2019-09-03 |
CN110197701B CN110197701B (zh) | 2021-08-10 |
Family
ID=67751980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910325039.3A Active CN110197701B (zh) | 2019-04-22 | 2019-04-22 | 一种新型多发性骨髓瘤诺模图构建方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110197701B (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101392285A (zh) * | 2006-09-21 | 2009-03-25 | 富士胶片株式会社 | 多发性骨髓瘤的检测方法及抑制方法 |
WO2010111208A1 (en) * | 2009-03-23 | 2010-09-30 | University Of Miami | Mitochondrial inhibitors and uses thereof |
CN101932724A (zh) * | 2007-10-05 | 2010-12-29 | 环太平洋生物技术有限公司 | 胃肠癌的增生标签及预后 |
CN102186987A (zh) * | 2008-04-24 | 2011-09-14 | 阿肯色大学托管委员会 | 一种基于基因表达谱的用来标示高风险多发性骨髓瘤的基因组指纹的方法和用途 |
CN107463796A (zh) * | 2017-07-12 | 2017-12-12 | 北京航空航天大学 | 基于基因共表达网络传播分析的早期致病因子探测方法 |
CN108470111A (zh) * | 2018-05-09 | 2018-08-31 | 中国科学院昆明动物研究所 | 一种基于多基因表达特征谱的胃癌个性化预后评估方法 |
CN108733980A (zh) * | 2018-05-09 | 2018-11-02 | 中国科学院昆明动物研究所 | 一种基于多基因表达特征谱的胶质母细胞瘤个性化预后评估方法 |
-
2019
- 2019-04-22 CN CN201910325039.3A patent/CN110197701B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101392285A (zh) * | 2006-09-21 | 2009-03-25 | 富士胶片株式会社 | 多发性骨髓瘤的检测方法及抑制方法 |
CN101932724A (zh) * | 2007-10-05 | 2010-12-29 | 环太平洋生物技术有限公司 | 胃肠癌的增生标签及预后 |
CN102186987A (zh) * | 2008-04-24 | 2011-09-14 | 阿肯色大学托管委员会 | 一种基于基因表达谱的用来标示高风险多发性骨髓瘤的基因组指纹的方法和用途 |
WO2010111208A1 (en) * | 2009-03-23 | 2010-09-30 | University Of Miami | Mitochondrial inhibitors and uses thereof |
CN107463796A (zh) * | 2017-07-12 | 2017-12-12 | 北京航空航天大学 | 基于基因共表达网络传播分析的早期致病因子探测方法 |
CN108470111A (zh) * | 2018-05-09 | 2018-08-31 | 中国科学院昆明动物研究所 | 一种基于多基因表达特征谱的胃癌个性化预后评估方法 |
CN108733980A (zh) * | 2018-05-09 | 2018-11-02 | 中国科学院昆明动物研究所 | 一种基于多基因表达特征谱的胶质母细胞瘤个性化预后评估方法 |
Non-Patent Citations (4)
Title |
---|
PETER LANGFELDER 等: "WGCNA: an R package for weighted correlation network analysis", 《BMC BIOINFORMATICS》 * |
XIAO-PING LIU 等: "Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma", 《ORIGINAL RESEARCH》 * |
徐声鸣 等: "多发性骨髓瘤患者血清lncRNA HOTAIR表达量与血清β2微球蛋白及预后的相关性", 《中国实验诊断学》 * |
曲莹: "血清microRNA、长链非编码RNA及CRBN蛋白表达在多发性骨髓瘤中的临床意义", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 * |
Also Published As
Publication number | Publication date |
---|---|
CN110197701B (zh) | 2021-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110232974A (zh) | 一种新型多发性骨髓瘤综合风险评分方法 | |
Adhikari et al. | A GWAS in Latin Americans highlights the convergent evolution of lighter skin pigmentation in Eurasia | |
Holden et al. | Rapid radiation, borrowing and dialect continua in the Bantu languages | |
CN109478231A (zh) | 帮助区别良性和恶性放射线照相明显肺结节的方法和组合物 | |
CN105849279A (zh) | 用于识别疾病诱导的突变的方法和系统 | |
CN107422126A (zh) | 心血管危险事件预测及其用途 | |
JP2014521926A (ja) | 細胞におけるバイオマーカーの発現の積率による解析 | |
CN111524594A (zh) | 目标人群血液系统恶性肿瘤筛查系统 | |
CN113327679A (zh) | 一种肺栓塞临床风险及预后评分方法与系统 | |
CN113223714B (zh) | 一种用于预测子痫前期风险的基因组合、子痫前期风险预测模型及其构建方法 | |
JP2018517192A (ja) | 生物学的経路の関連性の評価を行うコンピュータ実装方法、コンピュータ・システム、およびコンピュータ・プログラム | |
CN116287204A (zh) | 检测特征基因的突变情况在制备静脉血栓栓塞症风险检测产品中的应用 | |
CN109929934A (zh) | 免疫相关基因在结直肠癌预后的试剂盒和系统中的应用 | |
CN107169264B (zh) | 一种复杂疾病诊断系统 | |
Li et al. | Current progress and future prospects in phylofloristics | |
CN110223733A (zh) | 一种新型多发性骨髓瘤预后基因的筛查方法 | |
KR102467999B1 (ko) | 위암의 다층 다요인 패널과 Computational biological network modeling을 통한 위암 발암에 대한 에티옴 모형 | |
CN106446601B (zh) | 一种大规模标注lncRNA功能的方法 | |
CN110197701A (zh) | 一种新型多发性骨髓瘤诺模图构建方法 | |
CN110218789A (zh) | 一种新型多发性骨髓瘤的基因探针检测组合物及试剂盒 | |
CN109811057A (zh) | 缺氧相关基因在结直肠癌预测系统中的应用 | |
CN114678062B (zh) | 基于多组学特征的肝细胞癌预后预测系统及其预测方法 | |
CN106650284B (zh) | 一种疾病康复评价系统 | |
CN115033758A (zh) | 肾透明细胞癌预后标记基因的应用及筛选、预后预测方法 | |
Avila Santos et al. | BioDeepfuse: a hybrid deep learning approach with integrated feature extraction techniques for enhanced non-coding RNA classification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220608 Address after: 1st and 2nd floors, No.21 Lane 908, Ziping Road, Pudong New Area, Shanghai, 200120 Patentee after: SHANGHAI TISSUEBANK MEDICAL LABORATORY Co.,Ltd. Address before: No.20, Chazhong Road, Taijiang District, Fuzhou City, Fujian Province Patentee before: THE FIRST AFFILIATED HOSPITAL OF FUJIAN MEDICAL University |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A new method for constructing nomographs of Multiple myeloma Effective date of registration: 20230719 Granted publication date: 20210810 Pledgee: Industrial Bank Co.,Ltd. Shanghai Nanhui Branch Pledgor: SHANGHAI TISSUEBANK MEDICAL LABORATORY Co.,Ltd.|SHENZHEN TISSUEBANK PRECISION MEDICINE CO.,LTD.|SHANGHAI TISSUEBANK BIOTECHNOLOGY Co.,Ltd.|Shanghai dishuobeiken Gene Technology Co.,Ltd.|SHANGHAI TISSUEBANK BIOTECHNOLOGY CO.,LTD. Registration number: Y2023310000384 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20210810 Pledgee: Industrial Bank Co.,Ltd. Shanghai Nanhui Branch Pledgor: SHANGHAI TISSUEBANK MEDICAL LABORATORY Co.,Ltd.|SHENZHEN TISSUEBANK PRECISION MEDICINE CO.,LTD.|SHANGHAI TISSUEBANK BIOTECHNOLOGY Co.,Ltd.|Shanghai dishuobeiken Gene Technology Co.,Ltd.|SHANGHAI TISSUEBANK BIOTECHNOLOGY CO.,LTD. Registration number: Y2023310000384 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A novel nomogram construction method for multiple myeloma Granted publication date: 20210810 Pledgee: Industrial Bank Co.,Ltd. Shanghai Nanhui Branch Pledgor: SHANGHAI TISSUEBANK MEDICAL LABORATORY Co.,Ltd.|SHENZHEN TISSUEBANK PRECISION MEDICINE CO.,LTD.|SHANGHAI TISSUEBANK BIOTECHNOLOGY Co.,Ltd.|Shanghai dishuobeiken Gene Technology Co.,Ltd.|SHANGHAI TISSUEBANK BIOTECHNOLOGY CO.,LTD. Registration number: Y2024310000533 |